Marker Therapeutics, Inc. (MRKR): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$375.0K
Year ended 2019-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | $375.0K | +153.9% | 2020-03-12, From 2019-01-01 |
| 2018-12-31 | $147.7K | n/a | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | $0 | n/a | 2019-03-15, From 2017-01-01 |